著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Yuichiro Ohe and Fumio Imamura and Naoyuki Nogami and Isamu Okamoto and Takayasu Kurata and Terufumi Kato and Shunichi Sugawara and Suresh S Ramalingam and Hirohiko Uchida and Rachel Hodge and Sarah L Vowler and Andrew Walding and Kazuhiko Nakagawa,Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset,Japanese Journal of Clinical Oncology,1465-3621,Oxford University Press (OUP),2018-12-01,49,1,29-36,https://cir.nii.ac.jp/crid/1362262943667966336,https://doi.org/10.1093/jjco/hyy179